Study Title: Randomized Phase II/III Trial of First Line Platinum/Etoposide with or without Atezolizumab (NSC #783608) in Patients with Advanced or Metastatic Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas (NEC)
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, O'Brien, Paul, at obrienpe@musc.edu.Study Coordinator, Sanders, Bria, at sandebri@musc.edu.Trial opened at the following institutions: Medical University of South Carolina